Charmaine Pelayo
Nurse Practitioner · Chicago Ridge, ILNPI 1366084725
Payments from drug & device makers
Across 215 payments — averaging $18.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$978
- AstraZeneca$468
- Regeneron Healthcare Solutions, Inc.$308
- Sanofi$261
- Jazz Pharmaceuticals Inc.$252
- Actelion Pharmaceuticals US, Inc.$243
- plus $1K from 15 others
What the payments were for
- Food & beverage$4,004100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 68 | $978 |
| AstraZeneca | 28 | $468 |
| Regeneron Healthcare Solutions, Inc. | 12 | $308 |
| Sanofi | 12 | $261 |
| Jazz Pharmaceuticals Inc. | 5 | $252 |
| Actelion Pharmaceuticals US, Inc. | 10 | $243 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $231 |
| Boehringer Ingelheim | 9 | $214 |
| Insmed, Inc. | 10 | $204 |
| Grifols USA, LLC | 7 | $149 |
| Electromed, Inc. | 13 | $138 |
| United Therapeutics Corporation | 5 | $121 |
| Inogen, Inc. | 7 | $108 |
| Teva Pharmaceuticals USA, Inc. | 4 | $63 |
| Amgen | 3 | $60 |
| Genentech USA, Inc. | 3 | $51 |
| Baxter Healthcare | 2 | $44 |
| Merck | 2 | $31 |
| Philips North America LLC | 2 | $30 |
| Novartis | 2 | $28 |
| Verona Pharma, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XYWAV$150
How this compares
$4,004 in reported general payments places this provider in the 90th percentile of 4,869 nurse practitioner providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 125 | $118,052 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 73 | $40,017 |
| Breo ElliptaFluticasone/Vilanterol | 23 | $10,232 |
| Atrovent HfaIpratropium Bromide | 20 | $9,652 |
| Incruse ElliptaUmeclidinium Bromide | 25 | $9,266 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 180 | $7,963 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 12 | $4,837 |
| Ventolin HfaAlbuterol Sulfate | 20 | $1,483 |
| Roflumilast | 14 | $1,317 |
| Montelukast Sodium | 35 | $549 |
| Azithromycin | 36 | $206 |
| Prednisone | 53 | $93 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Incruse Ellipta | $978 | $177,566246 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,869 nurse practitioner providers in Illinois.
Other nurse practitioner in Chicago Ridge
- Erika VuckoChicago$417K
- Deepa VallikatWest Dundee$332K
- Maria MalotoNaperville$135K
- Valerie LaroyOak Lawn$112K
- Jennifer LiebChampaign$109K
- Tanya MungerRockford$106K
- Kristy LukeChicago$77K
- Yvonna OldakerFlossmoor$74K
- Heather PiercePekin$72K
- Dara McKinleyEvanston$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.